Current:Home > reviewsVeteran Taj Gibson rejoining New York Knicks, reuniting with Thibodeau -Global Finance Compass
Veteran Taj Gibson rejoining New York Knicks, reuniting with Thibodeau
View
Date:2025-04-12 17:46:07
NEW YORK (AP) — Taj Gibson is returning to the New York Knicks, reuniting coach Tom Thibodeau with one of his trusted veteran players.
Priority Sports, which represents Gibson, posted on social media Wednesday that the Brooklyn product was heading home to play for the Knicks, who are in need of big man help after starting center Mitchell Robinson was lost for at least two months with a stress fracture in his left ankle.
Gibson played for the Knicks from 2019-22, helping them return to the postseason in 2021 after a seven-year absence. He then spent one season with the Washington Wizards.
The 38-year-old Gibson, a first-round pick in the 2009 draft, previously played for Thibodeau in Chicago and Minnesota. He has career averages of 8.7 points and 5.9 rebounds.
___
AP NBA: https://apnews.com/hub/NBA
veryGood! (6174)
Related
- South Korean president's party divided over defiant martial law speech
- District attorney drops case against Nate Diaz for New Orleans street fight
- Michigan woman will serve up to 5 years in prison for crash into icy pond that killed her 3 sons
- Sophie Turner and Joe Jonas Reach Temporary Agreement Over 2 Kids Amid Lawsuit
- Former Syrian official arrested in California who oversaw prison charged with torture
- In letter, Mel Tucker claims Michigan State University had no basis for firing him
- UN rights experts decry war crimes by Russia in Ukraine and look into genocide allegations
- The chairman of Hong Kong’s leading journalist group gets jail term for obstructing a police officer
- 2 killed, 3 injured in shooting at makeshift club in Houston
- Video shows landmark moment when sample of asteroid Bennu touches down on Earth
Ranking
- Elon Musk's skyrocketing net worth: He's the first person with over $400 billion
- After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
- If you struggle with seasonal allergies, doctors recommend you try this
- China’s top diplomat calls on US to host an APEC summit that is cooperative, not confrontational
- Trump invites nearly all federal workers to quit now, get paid through September
- Wisconsin state Senate’s chief clerk resigns following undisclosed allegation
- Bill Belichick delivers classic line on Taylor Swift-Travis Kelce relationship
- Turks and Caicos Islands judge delivers mixed verdict in high-profile government corruption case
Recommendation
Rolling Loud 2024: Lineup, how to stream the world's largest hip hop music festival
Egypt sets a presidential election for December with el-Sissi likely to stay in power until 2030
Sparkling water is popular, but is it healthy?
Inside Consumer Reports
Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
Is US migrant surge result of 'a broken and failed system?'
In letter, Mel Tucker claims Michigan State University had no basis for firing him
Kari Lake’s trial to review signed ballot envelopes from Arizona election wraps